Back
Akero Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.65
Seasonality Move:
1.27%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
Akero Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.65 | Sell |
| 20-day SMA: | 54.53 | Buy |
| 50-day SMA: | 54.21 | Buy |
| 200-day SMA: | 48.49 | Buy |
| 8-day EMA: | 54.63 | Buy |
| 20-day EMA: | 54.48 | Buy |
| 50-day EMA: | 53.37 | Buy |
| 200-day EMA: | 48.02 | Buy |
Akero Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.32 - 54.64) | Buy |
| Bollinger Bands (100): | (46.63 - 54.53) | Buy |
Akero Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akero Therapeutics, Inc. Stock
Is Akero Therapeutics, Inc. Stock a Buy?
-
Akero Therapeutics, Inc. share price is 54.65 while AKRO 8-day simple moving average is 54.65, which is a Sell signal.
-
The stock price of AKRO is 54.65 while Akero Therapeutics, Inc. 20-day SMA is 54.53, which makes it a Buy.
-
Akero Therapeutics, Inc. 50-day simple moving average is 54.21 while AKRO share price is 54.65, making it a Buy technically.
-
AKRO stock price is 54.65 and Akero Therapeutics, Inc. 200-day simple moving average is 48.49, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. a Buy or a Sell?
-
Akero Therapeutics, Inc. stock is rated a BuyThe current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics, Inc. Stock Info
Market Cap:
4.5B
Price in USD:
54.65
Share Volume:
0
Akero Therapeutics, Inc. 52-Week Range
52-Week High:
58.40
52-Week Low:
21.34
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Akero Therapeutics, Inc. Share Price Forecast
-
What is the Akero Therapeutics, Inc. stock price today?The Akero Therapeutics, Inc. stock price is 54.65 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics, Inc. is not overvalued.
Is Akero Therapeutics, Inc. Stock a Buy?
-
Akero Therapeutics, Inc. share price is 54.65 while AKRO 8-day exponential moving average is 54.63, which is a Buy signal.
-
The stock price of AKRO is 54.65 while Akero Therapeutics, Inc. 20-day EMA is 54.48, which makes it a Buy.
-
Akero Therapeutics, Inc. 50-day exponential moving average is 53.37 while AKRO share price is 54.65, making it a Buy technically.
-
AKRO stock price is 54.65 and Akero Therapeutics, Inc. 200-day simple moving average is 48.02, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics, Inc.
Is Akero Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Akero Therapeutics, Inc.
Should I short Akero Therapeutics, Inc. stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Akero Therapeutics, Inc. is a Buy
-
Akero Therapeutics, Inc. Relative Strength Index (RSI) is 69.15, which suggest Akero Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Akero Therapeutics, Inc. is (54.32 - 54.64), which suggest Akero Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics, Inc. is (46.63 - 54.53), which suggest Akero Therapeutics, Inc. is a Buy
* Akero Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.